litlas
ログインアカウント作成

George Wilding

1985–2024 年に発表

86
論文数
27,767
被引用数
80
h 指数
86
i10 指数

被引用数

George Wilding の年別被引用数1931 年: 被引用 1 件1953 年: 被引用 1 件1956 年: 被引用 1 件1986 年: 被引用 1 件1988 年: 被引用 1 件1989 年: 被引用 8 件1990 年: 被引用 11 件1991 年: 被引用 14 件1992 年: 被引用 17 件1993 年: 被引用 21 件1994 年: 被引用 17 件1995 年: 被引用 25 件1996 年: 被引用 27 件1997 年: 被引用 34 件1998 年: 被引用 37 件1999 年: 被引用 71 件2000 年: 被引用 72 件2001 年: 被引用 81 件2002 年: 被引用 99 件2003 年: 被引用 106 件2004 年: 被引用 125 件2005 年: 被引用 125 件2006 年: 被引用 220 件2007 年: 被引用 279 件2008 年: 被引用 237 件2009 年: 被引用 321 件2010 年: 被引用 277 件2011 年: 被引用 326 件2012 年: 被引用 211 件2013 年: 被引用 297 件2014 年: 被引用 250 件2015 年: 被引用 207 件2016 年: 被引用 224 件2017 年: 被引用 196 件2018 年: 被引用 202 件2019 年: 被引用 617 件2020 年: 被引用 580 件2021 年: 被引用 508 件2022 年: 被引用 361 件2023 年: 被引用 289 件2024 年: 被引用 444 件2025 年: 被引用 169 件2026 年: 被引用 3 件1932〜1952 年は被引用が無いため表示していません1954〜1955 年は被引用が無いため表示していません1957〜1985 年は被引用が無いため表示していません1987 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,118 件、この内訳の 29.9%イギリス: 引用元論文 725 件、この内訳の 7%ドイツ: 引用元論文 568 件、この内訳の 5.4%イタリア: 引用元論文 532 件、この内訳の 5.1%フランス: 引用元論文 527 件、この内訳の 5.1%中国: 引用元論文 522 件、この内訳の 5%カナダ: 引用元論文 519 件、この内訳の 5%オランダ: 引用元論文 370 件、この内訳の 3.6%日本: 引用元論文 338 件、この内訳の 3.2%スペイン: 引用元論文 315 件、この内訳の 3%オーストラリア: 引用元論文 280 件、この内訳の 2.7%ベルギー: 引用元論文 242 件、この内訳の 2.3%
0%29.9%その他 22.7%

機関

分野

  • Medicine67.8%
  • Biochemistry, Genetics and Molecular Biology22.7%
  • Immunology and Microbiology3.7%
  • Pharmacology, Toxicology and Pharmaceutics1.1%
  • Engineering0.8%
  • Chemistry0.6%
  • その他3.3%

トピック

  • Prostate Cancer Treatment and Research11.2%
  • Prostate Cancer Diagnosis and Treatment6.6%
  • Renal cell carcinoma treatment4.2%
  • Radiopharmaceutical Chemistry and Applications3.3%
  • Cancer Immunotherapy and Biomarkers2.1%
  • Angiogenesis and VEGF in Cancer1.9%
  • その他70.7%

共著者

全論文

検索で開く
  1. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    著者: Howard I. Scher, Michael J. Morris, Walter M. Stadler, Celestia S. Higano, Ethan Basch, Karim Fizazi, Emmanuel S. Antonarakis, Tomasz M. Beer, Michael A. Carducci, Kim N., Paul G. Corn, Johann S. de Bono, Robert Dreicer, Daniel J. George, Elisabeth I. Heath, Maha Hussain, Wm. Kevin Kelly, Glenn Liu, Christopher J. Logothetis, David M. Nanus, Mark N. Stein, Dana E. Rathkopf, Susan F. Slovin, Charles J. Ryan, Oliver Sartor, Eric J. Small, Matthew Raymond Smith, Cora N. Sternberg, Mary-Ellen Taplin, George Wilding, Peter S. Nelson, Lawrence H. Schwartz, Susan Halabi, Philip W. Kantoff, Andrew J. Armstrong - Journal of Clinical Oncology 2016 被引用: 1,603

  2. Therapy-Induced Senescence in Cancer

    著者: Jonathan A. Ewald, Joshua A. Desotelle, George Wilding, David F. Jarrard - JNCI Journal of the National Cancer Institute 2010 被引用: 824

  3. Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

    著者: Howard I. Scher, Susan Halabi, Ian F. Tannock, Michael J. Morris, Cora N. Sternberg, Michael A. Carducci, Mario A. Eisenberger, Celestia S. Higano, Glenn J. Bubley, Robert Dreicer, Daniel Petrylak, Philip W. Kantoff, Ethan Basch, William Kevin Kelly, William D. Figg, Eric J. Small, Tomasz M. Beer, George Wilding, Alison Martin, Maha Hussain - Journal of Clinical Oncology 2008 被引用: 2,241

  4. Intermittent versus Continuous Androgen Deprivation in Prostate Cancer

    著者: Maha Hussain, Catherine M. Tangen, Donna L. Berry, Celestia S. Higano, E. David Crawford, Glenn Liu, George Wilding, Stephen M. Prescott, S.K. Sundaram, Eric J. Small, Nancy A. Dawson, Bryan Donnelly, Peter Venner, Ulka N. Vaishampayan, Paul F. Schellhammer, David I. Quinn, Derek Raghavan, Benjamin Ely, Carol M. Moinpour, Nicholas J. Vogelzang, Ian M. Thompson - New England Journal of Medicine 2013 被引用: 568

  5. Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

    著者: Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak, M. Dror Michaelson, Ronald M. Bukowski, Stéphane Oudard, Sylvie Négrier, Cezary Szczylik, Роберто Пили, Georg A. Bjarnason, Xavier García del Muro, Jeffrey A. Sosman, E Solska, George Wilding, John A. Thompson, Sindy T. Kim, Isan Chen, Xin Huang, Robert A. Figlin - Journal of Clinical Oncology 2009 被引用: 2,189

  6. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial

    著者: Naomi B. Haas, Judith Manola, Robert G. Uzzo, Keith T. Flaherty, Christopher G. Wood, Christopher J. Kane, Michael A.S. Jewett, Janice P. Dutcher, Michael B. Atkins, Michael Pins, George Wilding, David Cella, Lynne I. Wagner, Surena F. Matin, Timothy M. Kuzel, Wade J. Sexton, Yu-Ning Wong, Toni K. Choueiri, Роберто Пили, Igor Puzanov, Manish Kohli, Walter M. Stadler, Michael A. Carducci, Robert Coomes, Robert S. DiPaola - The Lancet 2016 被引用: 638

  7. Absolute Prostate-Specific Antigen Value After Androgen Deprivation Is a Strong Independent Predictor of Survival in New Metastatic Prostate Cancer: Data From Southwest Oncology Group Trial 9346 (INT-0162)

    著者: Maha Hussain, Catherine M. Tangen, Celestia S. Higano, Paul F. Schelhammer, James R. Faulkner, E. David Crawford, George Wilding, A. Akdaş, Eric J. Small, Bryan Donnelly, Gary R. MacVicar, Derek Raghavan - Journal of Clinical Oncology 2006 被引用: 507

  8. Engineering a Prostate-Specific Membrane Antigen–Activated Tumor Endothelial Cell Prodrug for Cancer Therapy

    著者: Samuel R. Denmeade, Annastasiah Mhaka, Dina Rosen, W. Nathaniel Brennen, Susan L. Dalrymple, Ingrid Dach, Claus Olesen, Bora Gürel, Angelo M. De Marzo, George Wilding, Michael A. Carducci, Craig A. Dionne, Jesper V. Møller, Poul Nissen, S. Brøgger Christensen, John T. Isaacs - Science Translational Medicine 2012 被引用: 217

  9. The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial

    著者: Shahneen Sandhu, William R. Schelman, George Wilding, Víctor Moreno, Richard D. Baird, Susana Miranda, Lucy Hylands, Ruth Riisnaes, Martin Förster, Aurelius Omlin, N. Kreischer, Khin Thway, Heidrun Gevensleben, Linda Sun, John W. Loughney, Manash Chatterjee, Carlo Toniatti, Christopher L. Carpenter, Robert Iannone, Stan B. Kaye, Johann S. de Bono, Robert M. Wenham - The Lancet Oncology 2013 被引用: 558

  10. Sunitinib in Patients With Metastatic Renal Cell Carcinoma

    著者: Robert J. Motzer, Brian I. Rini, Ronald M. Bukowski, Brendan D. Curti, Daniel J. George, Gary R. Hudes, Bruce G. Redman, Kim Margolin, Jaime R. Merchan, George Wilding, Michelle S. Ginsberg, Jennifer Bacik, Sindy T. Kim, Charles M. Baum, M. Dror Michaelson - JAMA 2006 被引用: 1,228

  11. Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial

    著者: John C. Araujo, Géralyn C. Trudel, Fred Saad, Andrew J. Armstrong, Evan Y. Yu, Joaquim Bellmunt, George Wilding, John McCaffrey, Sérgio Serrano, В. Б. Матвеев, Eleni Efstathiou, Stéphane Oudard, Michael J. Morris, Bruce Sizer, Peter J. Goebell, Axel Heidenreich, Johann S. de Bono, Stephen Begbie, Jun Hyuk Hong, Eduardo Richardet, Enrique Gallardo, Prashni Paliwal, S DURHAM, Shinta Cheng, Christopher J. Logothetis - The Lancet Oncology 2013 被引用: 231

  12. Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours

    著者: Devalingam Mahalingam, George Wilding, Samuel R. Denmeade, J. Sarantopoulas, David Cosgrove, Jeremy Cetnar, Nilofer S. Azad, Justine Y. Bruce, Michael R. Kurman, Victoria Allgood, Michael A. Carducci - British Journal of Cancer 2016 被引用: 149

  13. Predicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network–Based Artificial Intelligence Tool

    著者: Savitri Krishnamurthy, Parag Jain, Debu Tripathy, Roland Basset, Ramandeep S. Randhawa, Muhammad Hassan, Wei Huang, Hua Yang, Shivaani Kummar, George Wilding, Rajat Roy - JCO Clinical Cancer Informatics 2023 被引用: 24

  14. Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma

    著者: Robert J. Motzer, M. Dror Michaelson, Bruce G. Redman, Gary R. Hudes, George Wilding, Robert A. Figlin, Michelle S. Ginsberg, Sindy T. Kim, Charles M. Baum, Samuel E. DePrimo, Jim Z. Li, Carlo L. Bello, Charles P. Theuer, Daniel J. George, Brian I. Rini - Journal of Clinical Oncology 2005 被引用: 1,632

  15. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy

    著者: Edward M. Messing, Judith Manola, Jorge L. Yao, Maureen Kiernan, David Crawford, George Wilding, P. Anthony diSant’Agnese, Donald L. Trump - The Lancet Oncology 2006 被引用: 905

  16. A Novel Artificial Intelligence–Powered Method for Prediction of Early Recurrence of Prostate Cancer After Prostatectomy and Cancer Drivers

    著者: Wei Huang, Ramandeep S. Randhawa, Parag Jain, Samuel Hubbard, Jens C. Eickhoff, Shivaani Kummar, George Wilding, Hirak S. Basu, Rajat Roy - JCO Clinical Cancer Informatics 2022 被引用: 30

  17. Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer

    著者: Douglas G. McNeel, Edward J. Dunphy, James G. Davies, Thomas Frye, Laura E. Johnson, Mary Jane Staab, Dorothea Horvath, Jane Straus, Dona Alberti, Rebecca Marnocha, Glenn Liu, Jens C. Eickhoff, George Wilding - Journal of Clinical Oncology 2009 被引用: 250

  18. Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma

    著者: Joshua M. Lang, Mahazarin R. Kaikobad, Marianne Wallace, Mary Jane Staab, Dorothea Horvath, George Wilding, Glenn Liu, Jens C. Eickhoff, Douglas G. McNeel, Miroslav Malkovský - Cancer Immunology Immunotherapy 2011 被引用: 132

  19. A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer

    著者: Dana E. Rathkopf, Joel Picus, Arif Hussain, Susan Ellard, Kim Nguyen, Thomas Nydam, E. Allen-Freda, Kaushal Mishra, Maria Grazia Porro, Howard I. Scher, George Wilding - Cancer Chemotherapy and Pharmacology 2013 被引用: 94

  20. Prostate-Specific Antigen Progression Predicts Overall Survival in Patients With Metastatic Prostate Cancer: Data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916

    著者: Maha Hussain, Bryan Goldman, Cathy Tangen, Celestia S. Higano, Daniel P. Petrylak, George Wilding, A. Akdaş, Eric J. Small, Bryan Donnelly, Subramanian Kanaga Sundram, Patrick A. Burch, Robert S. DiPaola, E. David Crawford - Journal of Clinical Oncology 2009 被引用: 216

  21. Prooxidant-Antioxidant Shift Induced by Androgen Treatment of Human Prostate Carcinoma Cells

    著者: Maureen O. Ripple, George Wilding, William F. Henry, Randall Rago - JNCI Journal of the National Cancer Institute 1997 被引用: 311

  22. An Open-Label, Multicenter, Phase I/II Study of Single-Agent AT-101 in Men with Castrate-Resistant Prostate Cancer

    著者: Glenn Liu, William K. Kelly, George Wilding, Lance Leopold, Kimberli J. Brill, Bradley G. Somer - Clinical Cancer Research 2009 被引用: 181

  23. Volociximab, a Chimeric Monoclonal Antibody that Specifically Binds α5β1 Integrin: A Phase I, Pharmacokinetic, and Biological Correlative Study

    著者: Alejandro D. Ricart, Anthony W. Tolcher, Glenn Liu, Kyle D. Holen, Garry Schwartz, Mark R. Albertini, Geoffrey R. Weiss, Salim Yazji, Chee M. Ng, George Wilding - Clinical Cancer Research 2008 被引用: 158

  24. Phase I Trial of a Monoclonal Antibody Specific for αvβ3 Integrin (MEDI-522) in Patients with Advanced Malignancies, Including an Assessment of Effect on Tumor Perfusion

    著者: Douglas G. McNeel, Jens C. Eickhoff, Fred T. Lee, David M. King, Dona Alberti, James P. Thomas, Andreas Friedl, Jill Kolesar, Rebecca Marnocha, Jennifer Volkman, Jianliang Zhang, Luz Hammershaimb, James A. Zwiebel, George Wilding - Clinical Cancer Research 2005 被引用: 158